Condition
Cardiovascular Events clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Cardiovascular Events clinical trials that are recruiting, at sites in 9 countries (most in United States (3), China (3), Germany (2)). By phase: Phase 3 (2), Phase 4 (1). There are also 14 NIH-funded research projects on Cardiovascular Events, with $9.1 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 14NIH research projects
- 9Countries
Newest Cardiovascular Events clinical trials
All recruiting trials (10)
-
Cardiovascular outcomes after hematopoietic stem cell transplantation
We will collect clinical, laboratory, and treatment data from people who had hematopoietic stem cell transplants to see if certain factors are linked to heart and blood vessel problems after transplant.
-
Rosuvastatin to help prevent blood clots in cancer patients
This study tests whether taking rosuvastatin daily for a year can lower the chance of dangerous blood clots in people with newly diagnosed or relapsed cancer who aren’t planned to receive blood-thinning medicine.
-
Continuing versus stopping daily aspirin before colonoscopy with possible polyp removal
This trial tests whether people taking daily low‑dose aspirin to prevent heart problems should keep taking aspirin or stop it before an elective colonoscopy with possible polyp removal to balance heart and bleeding risks.
-
Low-dose colchicine to prevent heart problems in people with moderate chronic kidney disease
This trial will test whether taking low-dose colchicine reduces future cardiovascular events in adults with moderate chronic kidney disease who have had prior heart or vascular problems.
-
Heart-event monitoring for people with severe asthma taking Tezepelumab (Tezspire)
This project will test whether taking tezepelumab (Tezspire) changes the risk of serious heart problems in adolescents and adults with severe asthma compared with high-intensity standard care.
-
Using PCSK9 inhibitors to lower cholesterol in patients with high-risk coronary plaques
This study tests if adding a new cholesterol-lowering medication to standard treatment can help people with high-risk heart plaques avoid serious heart and brain problems.
-
Assessing Carotid Plaque Vulnerability to Predict Stroke and Heart Events
This study is trying to see if special ultrasound tests can help predict the risk of strokes and heart problems in people with plaque in their carotid arteries.
-
Comparing two flu vaccines for older adults
This study is testing which of two flu vaccines works better for adults aged 65 and older to prevent the flu and related health issues.
-
Investigating how menopause affects blood cell function and cardiovascular risk
This study is testing how menopause affects blood cells and heart health in both men and women to see if hormone changes increase cardiovascular risks, especially looking at the role of hormone replacement therapy.
-
Using non-invasive tests to predict cardiovascular events in patients with abdominal aortic aneurysm
This study is trying to see if non-invasive tests can help predict serious heart problems in patients with abdominal aortic aneurysm who are getting treatment.
NIH-funded research (14)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
How air pollution affects recurrent heart events in older adults
This grant explores how air pollution, especially PM2.5, influences the recurrence and progression of heart problems in people aged 65 and older.
-
Complete reproductive history and its link to maternal death and serious heart problems
A study using birth and health records to understand how a woman’s pregnancy history may relate to serious heart and maternal health outcomes later in life.
-
Aspirin, Lp(a), and heart-health in adults over 65 with diabetes
A heart-healthy question for older adults with diabetes: does aspirin help prevent first cardiovascular events in people with high Lp(a) levels?
-
Bayesian modeling to understand recurring heart problems in older adults with cancer
A new statistical approach will help identify and predict repeated cardiovascular problems in older cancer patients treated with immune therapies.
-
SKNA as a biomarker to guide heart and brain health
A biomarker from skin nerve signals (SKNA) could help predict brain recovery after cardiac arrest and identify those at risk for atrial fibrillation recurrence after ablation.
-
Molecular clues to heart risk and resilience in chronic coronary artery disease
Researchers will look at molecular markers to better predict heart attack risk and resilience in people with chronic CAD, using advanced data from large heart disease studies.
-
Aspirin, Lp(a), and Preventing Heart Problems
This work explores if aspirin can help prevent heart and blood vessel problems in people with high levels of a specific fat particle called Lp(a), especially those with type 2 diabetes.
-
Identifying molecular factors that predict heart events in chronic coronary artery disease
This study is looking for new ways to understand and predict heart problems in people with chronic coronary artery disease, so that doctors can tailor treatments to each person’s needs and help them live healthier lives.
-
Using skin nerve activity to predict heart-related health outcomes
This study is looking at how measuring nerve activity in the skin can help doctors understand how well patients are recovering after a cardiac arrest and if they might have heart rhythm problems again after treatment, using techniques that have worked well in dogs.
-
Investigating the role of aspirin in preventing cardiovascular events related to elevated Lp(a) levels.
This study is looking at whether taking aspirin can help prevent heart problems in people who have high levels of a genetic marker called Lp(a), especially those over 65 or with type 2 diabetes, so that doctors can give better advice to patients at risk for heart disease.
-
Investigating how alcohol affects heart health through gut interactions
This study is looking at how binge drinking affects heart health and aims to understand the connection between alcohol, the gut, and the heart, using mice to find out how certain substances in the body might impact heart function after drinking.
-
Identifying risk factors for heart problems in COVID-19 patients
This study is looking at what makes some people more likely to have heart problems after being hospitalized with COVID-19, so we can better understand their needs and improve their care.
-
How airway irritants affect heart health in people with cardiovascular disease
This study is looking at how air pollution can affect people with heart problems by triggering harmful reactions in their bodies, and it hopes to find better ways to help those at risk.
-
How air pollution affects heart disease recurrence
This study is looking at how breathing in tiny air pollution particles might affect people who have heart problems, helping us understand how to better prevent heart issues and improve health policies for everyone.
Related topics
Quick answers
How many Cardiovascular Events clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in United States (3 trials), China (3 trials), Germany (2 trials), South Korea (1 trial), Hong Kong (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.